Please join us for this annual celebration of collaborative research. The entire C3 community is invited to attend. The theme of the 2022 symposium is “Advances in Immuno-Oncology Research†and will focus on the developments in this exciting area of research.
In partnership with 
A reception will follow the symposium and virtual access to the symposium will be available.
Keynote Speaker
Jeff Settleman, PhD
Chief Scientific Officer
Pfizer
Director and Professor
Tumor Initiation and Maintenance Program
NCI-Designated Cancer Center
Sanford Burnham Prebys
mt-1
Associate Director, Basic Science
Distinguished Professor and Chair
Department of Pharmacology
UC San Diego Moores Cancer Center